1 results match your criteria: "and the Semmes Murphey Clinic[Affiliation]"
Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma.
N Engl J Med
November 2024
From the Department of Neurosurgery, Stony Brook Medicine, Stony Brook, NY (D.F.); the Department of Neurosurgery, Swedish Cherry Hill Hospital, Seattle (S.J.M.); the Department of Neurosurgery, Baptist Memorial Hospital, Jacksonville, FL (R.H.); the Department of Neurosurgery, Swedish Medical Center, Englewood, CO (B.A.); the Department of Neuroradiology, Rockefeller Neuroscience Institute, West Virginia University Medicine, Morgantown (S.B.); the Department of Radiology, Rhode Island Hospital, Providence (R.A.M.); the Department of Neurosurgery, Santa Barbara Cottage Hospital, Santa Barbara, CA (A.Z.); the Department of Neurosurgery, Thomas Jefferson Hospital, Philadelphia (S.T.); the Department of Radiology, Centre Hospitalier Universitaire (CHU) Côte de Nacre, Caen (C.B.), the Department of Radiology, CHU Hôpital Bicêtre, Kremlin-Bicêtre (L.S.), and the Department of Radiology, CHU Hôpital Maison Blanche, Reims (L.P.) - all in France; the Department of Neurosurgery, Atlantic Center for Research, Morristown, NJ (R.B.); the Department of Radiology, Massachusetts General Hospital, Boston (J.A.H.); and the Cerebrovascular Program, Vanderbilt University Medical Center, Nashville (M.F.), and the Department of Neurosurgery, University of Tennessee Health Science Center, and the Semmes Murphey Clinic, Memphis (A.S.A.) - all in Tennessee.
Background: Patients receiving standard treatment for chronic subdural hematoma have a high risk of treatment failure. The effect of adjunctive middle meningeal artery embolization on the risk of treatment failure in this population remains unknown.
Methods: We randomly assigned patients with symptomatic chronic subdural hematoma to undergo middle meningeal artery embolization as an adjunct to standard treatment (embolization group) or to receive standard treatment alone (control group).